Professional Documents
Culture Documents
Bio project
Bio project
Bio project
Introduction
Cervical cancer is a type of cancer that occurs in the cells of the cervix,
which is the lower part of the uterus that connects to the vagina. It is one of
the most common types of cancer in women worldwide. Cervical cancer
usually develops slowly over time, and it can be detected at an early stage
through regular screenings, such as the Pap smear test.
Cervical cancer typically starts in the cells on the surface of the cervix and
can then invade deeper into the cervix or spread to other parts of the body
if left untreated. It may not cause noticeable symptoms in its early stages,
which is why regular screenings are essential for early detection.
REASON
The primary cause of cervical cancer is persistent infection with certain types of
human papillomavirus (HPV). HPV is a sexually transmitted infection that is very
common. However, not all HPV infections lead to cervical cancer. There are several
factors that can increase the risk of developing cervical cancer:
1. HPV infection: Infection with high-risk types of HPV, particularly HPV types 16
and 18, is the most significant risk factor for cervical cancer. HPV is
transmitted through sexual contact, and long-term infection with high-risk
HPV types can lead to the development of cervical cancer.
2. Lack of HPV vaccination: Not receiving the HPV vaccine increases the risk of
developing cervical cancer. Vaccination against HPV is recommended for both
males and females before they become sexually active. The vaccine protects
against the most common high-risk HPV types.
3. Weakened immune system: Women with weakened immune systems, such as
those with HIV/AIDS or those taking immunosuppressive medications, have a
higher risk of developing cervical cancer. A strong immune system plays a
crucial role in clearing HPV infections.
4. Smoking: Smoking tobacco increases the risk of developing cervical cancer.
Chemicals in tobacco smoke can damage the DNA of cervical cells, making
them more susceptible to cancerous changes.
5. Long-term use of oral contraceptives: Women who have used oral
contraceptives for a long duration, typically five or more years, may have a
slightly higher risk of developing cervical cancer. However, this risk returns to
normal after stopping the use of oral contraceptives.
6. Multiple sexual partners: Having multiple sexual partners or engaging in
sexual activity at an early age increases the risk of HPV infection, which, in
turn, increases the risk of developing cervical cancer.
7. History of sexually transmitted infections (STIs): Some STIs, such as chlamydia
and gonorrhea, can increase the risk of cervical cancer. These infections can
cause inflammation and damage to the cervix, making it more susceptible to
HPV infection.
It's important to note that while these factors increase the risk of developing cervical
cancer, many women with one or more risk factors do not develop the disease.
Regular screening, such as Pap smears or HPV testing, is crucial for early detection
and intervention.
DISCOVERY
The discovery and understanding of cervical cancer as a distinct form of cancer
involved the contributions of several researchers over time. However, the early
recognition and understanding of cervical cancer can be attributed to Dr. George
Nicholas Papanicolaou, a Greek-born American pathologist.
In the 1920s, Dr. Papanicolaou began studying cells under a microscope to develop a
screening test for early detection of cervical cancer. He collected samples from
women and observed cellular changes in the cervix. His groundbreaking work led to
the development of the Pap smear test, which is still widely used today for cervical
cancer screening.
The Pap smear, or Papanicolaou test, involves collecting cells from the cervix and
examining them under a microscope for abnormalities. This test allows for the early
detection of precancerous and cancerous changes in the cervix, enabling timely
intervention and treatment.
TREATMENTS
The treatment options for cervical cancer depend on several factors, including the
stage of the cancer, the size and location of the tumor, and the overall health of the
individual. The main treatment modalities for cervical cancer include:
1. Surgery: Surgical procedures may be used to remove the cancerous tissue. The
type of surgery performed depends on the stage of the cancer and may
include:
Cone biopsy: Removal of a cone-shaped piece of tissue from the cervix
containing the cancerous cells.
Radical trachelectomy: Removal of the cervix, upper vagina, and lymph nodes
while preserving fertility in select cases.
Radical hysterectomy: Removal of the uterus, cervix, upper vagina, and nearby
lymph nodes.
Pelvic exenteration: Extensive surgery to remove the uterus, cervix, vagina,
nearby lymph nodes, and other adjacent structures in advanced cases.
2. Radiation therapy: Radiation therapy uses high-energy X-rays or radioactive
substances to kill cancer cells or prevent their growth. It can be administered
externally (external beam radiation) or internally (brachytherapy). Radiation
therapy may be used alone or in combination with other treatments, such as
surgery or chemotherapy.
3. Chemotherapy: Chemotherapy involves the use of drugs to kill cancer cells. It
can be administered orally or intravenously and may be used before surgery
(neoadjuvant chemotherapy), after surgery (adjuvant chemotherapy), or in
combination with radiation therapy (chemoradiation). Chemotherapy can also
be used to treat recurrent or advanced cervical cancer.
4. Targeted therapy: Targeted therapy uses drugs that specifically target certain
molecules or pathways involved in cancer growth. For cervical cancer, targeted
therapy may involve the use of drugs that target the epidermal growth factor
receptor (EGFR), such as cetuximab.
5. Immunotherapy: Immunotherapy is a treatment that uses the body's immune
system to fight cancer. It can enhance the immune response against cancer
cells. Immunotherapy drugs, such as pembrolizumab or nivolumab, may be
used for the treatment of advanced or recurrent cervical cancer.
Stage 0 (Carcinoma in situ): In this stage, also known as carcinoma in situ or pre-
invasive cervical cancer, abnormal cells are present in the inner lining of the cervix
(the surface layer or epithelium), but they have not invaded deeper tissues or spread
to nearby lymph nodes. Stage 0 is considered a non-invasive form of cervical cancer.
Stage IA: The cancer is confined to the cervix and can only be detected
microscopically. It has not spread to the deeper cervical tissues or beyond.
Stage IB: The cancer is visible to the naked eye or can be detected during a
physical examination. It may involve a larger area of the cervix or may have
invaded the tissues around the cervix.
Stage II: In stage II, the cancer has spread beyond the cervix but is still confined to
the pelvic area. Stage II is further divided into two subcategories:
Stage IIA: The cancer has spread to the upper two-thirds of the vagina but has
not reached the tissues around the uterus (parametrium).
Stage IIB: The cancer has spread to the tissues around the uterus
(parametrium) but has not extended to the pelvic sidewall or to the lower part
of the vagina.
Stage III: In stage III, the cancer has spread to the lower part of the vagina, the pelvic
sidewall, or may cause kidney problems. Stage III is further divided into two
subcategories:
Stage IIIA: The cancer has spread to the lower third of the vagina but not to
the pelvic sidewall.
Stage IIIB: The cancer has extended to the pelvic sidewall or is causing kidney
problems (hydronephrosis) due to the blockage of the ureters.
Stage IV: Stage IV is the most advanced stage of cervical cancer. In this stage, the
cancer has spread beyond the pelvic area to other parts of the body, such as the
bladder, rectum, or distant organs (metastasis). Stage IV is further divided into two
subcategories:
Stage IVA: The cancer has spread to nearby organs, such as the bladder or
rectum.
Stage IVB: The cancer has spread to distant organs, such as the lungs, liver, or
bones.
The staging of cervical cancer helps guide treatment decisions and prognosis. The
earlier the stage at diagnosis, the higher the chances of successful treatment. It's
important to consult with a healthcare professional for an accurate staging
assessment and to discuss the appropriate treatment options for your specific
situation.